A carregar...
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
OBJECTIVES: While most women with ovarian cancer will achieve complete remission after treatment, the majority will relapse within two years, highlighting the need for novel therapies. Cancer stem cells (CSC) have been identified in ovarian cancer and most other carcinomas as a small population of c...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3906852/ https://ncbi.nlm.nih.gov/pubmed/23721800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.05.027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|